Advisornet Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.66M | Buy |
6,595
+397
| +6% | +$85.4K | 0.08% | 202 |
|
|
2026
Q1 | $1.35M | Sell |
6,198
-188
| -3% | -$41.7K | 0.07% | 219 |
|
|
2025
Q4 | $1.46M | Buy |
6,386
+303
| +5% | +$69K | 0.08% | 204 |
|
|
2025
Q3 | $1.41M | Sell |
6,083
-99
| -2% | -$20.2K | 0.08% | 203 |
|
|
2025
Q2 | $1.15M | Sell |
6,182
-64
| -1% | -$11.9K | 0.07% | 223 |
|
|
2025
Q1 | $1.31M | Buy |
6,246
+593
| +10% | +$115K | 0.1% | 204 |
|
|
2024
Q4 | $1M | Sell |
5,653
-814
| -13% | -$150K | 0.08% | 208 |
|
|
2024
Q3 | $1.28M | Buy |
6,467
+1,701
| +36% | +$317K | 0.1% | 202 |
|
|
2024
Q2 | $818K | Buy |
4,766
+242
| +5% | +$40.1K | 0.07% | 230 |
|
|
2024
Q1 | $824K | Buy |
4,524
+1,000
| +28% | +$172K | 0.08% | 233 |
|
|
2023
Q4 | $546K | Buy |
3,524
+79
| +2% | +$11.5K | 0.05% | 301 |
|
|
2023
Q3 | $513K | Sell |
3,445
-5,610
| -62% | -$824K | 0.05% | 302 |
|
|
2023
Q2 | $1.22M | Sell |
9,055
-463
| -5% | -$67.9K | 0.1% | 192 |
|
|
2023
Q1 | $1.52M | Sell |
9,518
-1,544
| -14% | -$236K | 0.14% | 155 |
|
|
2022
Q4 | $1.79M | Sell |
11,062
-8,701
| -44% | -$1.33M | 0.18% | 140 |
|
|
2022
Q3 | $2.65M | Buy |
19,763
+2,562
| +15% | +$368K | 0.26% | 95 |
|
|
2022
Q2 | $2.63M | Sell |
17,201
-1,852
| -10% | -$283K | 0.26% | 99 |
|
|
2022
Q1 | $3.09M | Sell |
19,053
-9,248
| -33% | -$1.34M | 0.19% | 116 |
|
|
2021
Q4 | $3.83M | Sell |
28,301
-7,971
| -22% | -$942K | 0.24% | 101 |
|
|
2021
Q3 | $3.91M | Sell |
36,272
-3,990
| -10% | -$456K | 0.27% | 80 |
|
|
2021
Q2 | $4.54M | Sell |
40,262
-919
| -2% | -$104K | 0.3% | 79 |
|
|
2021
Q1 | $4.46M | Buy |
41,181
+318
| +0.8% | +$34K | 0.32% | 73 |
|
|
2020
Q4 | $4.38M | Buy |
40,863
+945
| +2% | +$90.8K | 0.35% | 59 |
|
|
2020
Q3 | $3.5M | Buy |
39,918
+143
| +0.4% | +$13.5K | 0.3% | 73 |
|
|
2020
Q2 | $3.9M | Sell |
39,775
-2,070
| -5% | -$182K | 0.31% | 70 |
|
|
2020
Q1 | $3.19M | Buy |
41,845
+3,877
| +10% | +$330K | 0.29% | 79 |
|
|
2019
Q4 | $3.36M | Buy |
37,968
+20
| +0.1% | +$1.66K | 0.29% | 75 |
|
|
2019
Q3 | $2.87M | Buy |
37,948
+10,048
| +36% | +$689K | 0.26% | 87 |
|
|
2019
Q2 | $2.03M | Sell |
27,900
-2,497
| -8% | -$196K | 0.22% | 101 |
|
|
2019
Q1 | $2.45M | Buy |
30,397
+2,364
| +8% | +$193K | 0.3% | 78 |
|
|
2018
Q4 | $2.58M | Buy |
28,033
+107
| +0.4% | +$9.41K | 0.36% | 59 |
|
|
2018
Q3 | $2.64M | Buy |
27,926
+1,196
| +4% | +$113K | 0.33% | 64 |
|
|
2018
Q2 | $2.48M | Buy |
26,730
+117
| +0.4% | +$11.4K | 0.33% | 60 |
|
|
2018
Q1 | $2.52M | Buy |
26,613
+508
| +2% | +$55.8K | 0.35% | 59 |
|
|
2017
Q4 | $2.52M | Buy |
+26,105
| New | +$2.46M | 0.38% | 55 |
|
Other funds holding ABBV
Advisornet Financial's ABBV Position: Q2 2026 in Review
Advisornet Financial increased its AbbVie (ABBV) stake by 6.4% in Q2 2026, buying an estimated $85.4K and bringing the position to 6,595 shares worth $1.66M. The position accounts for 0.08% of the portfolio, ranked #202.
Advisornet Financial first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $4.54M in Q2 2021. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Advisornet Financial held 6,595 shares of AbbVie worth $1.66M as of Q2 2026.
- Advisornet Financial bought 397 AbbVie shares in Q2 2026, an estimated $85.4K.
- AbbVie made up 0.08% of Advisornet Financial's portfolio in Q2 2026, its #202 holding.
- Advisornet Financial first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's AbbVie position peaked at $4.54M in Q2 2021.
- 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.